SCHEMBL7248508

SCHEMBL7248508

N#Cc1ccc(C2(NC(=O)Nc3cccc(C#N)c3)CCCCCC2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.60
ALDH1A1 P00352 3/20 0.60
MEN1 O00255 2/20 0.60
MAPT P10636 2/20 0.60
TSHR P16473 2/20 0.51
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
HSD17B10 Q99714 2/20 0.47
GAA P10253 1/20 0.47
ALOX15 P16050 1/20 0.47
CASP7 P55210 1/20 0.47
MCHR1 Q99705 1/20 0.47
GRM5 P41594 1/20 0.47
HIF1A Q16665 1/20 0.45
HTT P42858 1/20 0.43
LMNA P02545 1/20 0.43
CYP2D6 P10635 2/20 0.43
CYP1A2 P05177 1/20 0.43
NSD2 O96028 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6584209 0.92 TSHR (0.51) KMT2AALDH1A1MEN1MAPTTSHR
SCHEMBL7248325 0.81 KMT2A (0.57) KMT2AALDH1A1MEN1MAPTTSHR
SCHEMBL7248947 0.76 MAPT (1.00) KMT2AALDH1A1MEN1MAPTTSHR
SCHEMBL30606801 0.76 MAPT (0.87) KMT2AALDH1A1MEN1MAPTNPC1
SCHEMBL29580531 0.76 MAPT (0.87) KMT2AALDH1A1MEN1MAPTNPC1
SCHEMBL6582903 0.75 GRM5 (0.51) KMT2AALDH1A1MEN1MAPTTSHR
SCHEMBL7249887 0.73 PLAU (0.45) NPC1RAB9AALOX15
SCHEMBL6583907 0.73 ROCK2 (0.50) KMT2AALDH1A1MEN1MAPTTSHR
SCHEMBL1608427 0.72 VNN1 (0.42) NPC1RAB9AGAAHTT
SCHEMBL6991463 0.72 TSHR (0.51) KMT2AALDH1A1MEN1MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6521614-B1 Anticoagulant agents for treatment and prevention of thromboembolic disorders BRISTOL-MYERS SQUIBB PHARMA COMPANY 2003-02-18 US disclosed
EP-0960104-A1 N-(AMIDINOPHENYL)-N'-(SUBST.)-3H-2,4-BENZODIAZEPIN-3-ONE DERIVATIVES AS FACTOR XA INHIBITORS Du Pont Pharmaceuticals Company (US) 1999-12-01 EP disclosed
US-5925635-A 2-(OXO-1,3-PERHYDRODIAZEPINES OR 3-OXO-2,3,4,5-TETRAHYDRO-1H-2,4-BENZODIAZEPINES; ANTICOAGULANTS; ENZYME INHIBITORS OF SERINE PROTEASE THROMBIN, KALLIKREIN AND PLASMIN; NERVOUS SYSTEM DISORDERS; ANTIINFLAMMATORY AGENTS DUPONT PHARMACEUTICALS COMPANY (US) 1999-07-20 US disclosed
WO-1997038984-A1 N-(AMIDINOPHENYL)-N'-(SUBST.)-3H-2,4-BENZODIAZEPIN-3-ONE DERIVATIVES AS FACTOR XA INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 1997-10-23 WO disclosed